In vivo synergism of roxithromycin (RU 965) and interferon against Toxoplasma gondii
- PMID: 3105452
- PMCID: PMC174724
- DOI: 10.1128/AAC.31.2.346
In vivo synergism of roxithromycin (RU 965) and interferon against Toxoplasma gondii
Abstract
We investigated the activity of roxithromycin (RU 965) and gamma interferon alone and in combination in a murine model of toxoplasmic encephalitis. Roxithromycin at a dosage of 35 or 50 mg per mouse per day decreased mortality. Gamma interferon alone significantly prolonged time to death. When combined, the two agents were remarkably synergistic.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
